T cell Ig and mucin domain-containing protein 3 is recruited to the immune synapse, disrupts stable synapse formation, and associates with receptor phosphatases

Journal of Immunology

Volumn 192, Issue 2, 2014, Pages 782-791

  Clayton, Kiera L ^a   Haaland, Matthew S ^a   Douglas Vail, Matthew B ^a   Mujib, Shariq ^a   Chew, Glen M ^b   Ndhlovu, Lishomwa C ^b   Ostrowski, Mario A ^a,c,d,e  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF HAWAII   (United States)

^c UNIVERSITY OF TORONTO   (Canada)

^d MAPLE LEAF MEDICAL CLINIC   (Canada)

^e ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD148 ANTIGEN; CD45 ANTIGEN; ECALECTIN; KIDNEY INJURY MOLECULE 1; LEUKOCYTE ANTIGEN; PROTEIN KINASE LCK; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ARTICLE; CD8+ T LYMPHOCYTE; CYTOTOXIC T LYMPHOCYTE; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; IMMUNOLOGICAL SYNAPSE; IMMUNOREGULATION; LIPID RAFT; NORMAL HUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

ANTIGENS, CD45; CD8-POSITIVE T-LYMPHOCYTES; GALECTINS; HIV INFECTIONS; HUMANS; LYMPHOCYTE SPECIFIC PROTEIN TYROSINE KINASE P56(LCK); MEMBRANE PROTEINS; PHOSPHORIC MONOESTER HYDROLASES; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 3; SIGNAL TRANSDUCTION; SYNAPSES;

EID: 84892757187     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302663     Document Type: Article

References (48)

1. Pardoll, D. M. 2012. The blockade of immune checkpoints in cancer immunotherapy. Nat. Rev. Cancer 12: 252-264.
2. Sharpe, A. H., E. J. Wherry, R. Ahmed, and G. J. Freeman. 2007. The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8: 239-245. (Pubitemid 46745373)
3. Wherry, E. J., J. N. Blattman, K. Murali-Krishna, R. van der Most, and R. Ahmed. 2003. Viral persistence alters CD8 T-cell immunodominance and tissue distribution and results in distinct stages of functional impairment. J. Virol. 77: 4911-4927. (Pubitemid 36402840)
4. Jones, R. B., L. C. Ndhlovu, J. D. Barbour, P. M. Sheth, A. R. Jha, B. R. Long, J. C. Wong, M. Satkunarajah, M. Schweneker, J. M. Chapman, et al. 2008. Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J. Exp. Med. 205: 2763-2779.
5. Vali, B., R. B. Jones, A. Sakhdari, P. M. Sheth, K. Clayton, F. Y. Yue, G. Gyenes, D. Wong, M. B. Klein, S. Saeed, et al. 2010. HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression. Eur. J. Immunol. 40: 2493-2505.
6. Blackburn, S. D., H. Shin, W. N. Haining, T. Zou, C. J. Workman, A. Polley, M. R. Betts, G. J. Freeman, D. A. Vignali, and E. J. Wherry. 2009. Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection. Nat. Immunol. 10: 29-37.
7. Sakhdari, A., S. Mujib, B. Vali, F. Y. Yue, S. MacParland, K. Clayton, R. B. Jones, J. Liu, E. Y. Lee, E. Benko, et al. 2012. Tim-3 negatively regulates cytotoxicity in exhausted CD8+ T cells in HIV infection. PLoS ONE 7: e40146.
8. Freeman, G. J., J. M. Casasnovas, D. T. Umetsu, and R. H. DeKruyff. 2010. TIM genes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity. Immunol. Rev. 235: 172-189.
9. Monney, L., C. A. Sabatos, J. L. Gaglia, A. Ryu, H. Waldner, T. Chernova, S. Manning, E. A. Greenfield, A. J. Coyle, R. A. Sobel, et al. 2002. Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature 415: 536-541. (Pubitemid 34130609)
10. Hastings, W. D., D. E. Anderson, N. Kassam, K. Koguchi, E. A. Greenfield, S. C. Kent, X. X. Zheng, T. B. Strom, D. A. Hafler, and V. K. Kuchroo. 2009. TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines. Eur. J. Immunol. 39: 2492-2501.
11. Seki, M., S. Oomizu, K. M. Sakata, A. Sakata, T. Arikawa, K. Watanabe, K. Ito, K. Takeshita, T. Niki, N. Saita, et al. 2008. Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin. Immunol. 127: 78-88.
12. Ju, Y., N. Hou, J. Meng, X. Wang, X. Zhang, D. Zhao, Y. Liu, F. Zhu, L. Zhang, W. Sun, et al. 2010. T cell immunoglobulin-and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B. J. Hepatol. 52: 322-329.
13. Anderson, A. C., D. E. Anderson, L. Bregoli, W. D. Hastings, N. Kassam, C. Lei, R. Chandwaskar, J. Karman, E. W. Su, M. Hirashima, et al. 2007. Promotion of tissue inflammation by the immune receptor Tim-3 expressed on innate immune cells. Science 318: 1141-1143. (Pubitemid 350134897)
14. Baitsch, L., A. Legat, L. Barba, S. A. Fuertes Marraco, J. P. Rivals, P. Baumgaertner, C. Christiansen-Jucht, H. Bouzourene, D. Rimoldi, H. Pircher, et al. 2012. Extended co-expression of inhibitory receptors by human CD8 T-cells depending on differentiation, antigen-specificity and anatomical localization. PLoS ONE 7: e30852.
15. Ndhlovu, L. C., S. Lopez-Vergès, J. D. Barbour, R. B. Jones, A. R. Jha, B. R. Long, E. C. Schoeffler, T. Fujita, D. F. Nixon, and L. L. Lanier. 2012. Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity. Blood 119: 3734-3743.
16. Nakayama, M., H. Akiba, K. Takeda, Y. Kojima, M. Hashiguchi, M. Azuma, H. Yagita, and K. Okumura. 2009. Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation. Blood 113: 3821-3830.
17. Zhu, C., A. C. Anderson, A. Schubart, H. Xiong, J. Imitola, S. J. Khoury, X. X. Zheng, T. B. Strom, and V. K. Kuchroo. 2005. The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat. Immunol. 6: 1245-1252. (Pubitemid 43045636)
18. Katoh, S., N. Ishii, A. Nobumoto, K. Takeshita, S. Y. Dai, R. Shinonaga, T. Niki, N. Nishi, A. Tominaga, A. Yamauchi, and M. Hirashima. 2007. Galectin-9 inhibits CD44-hyaluronan interaction and suppresses a murine model of allergic asthma. Am. J. Respir. Crit. Care Med. 176: 27-35. (Pubitemid 47048051)
19. Bi, S., P. W. Hong, B. Lee, and L. G. Baum. 2011. Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc. Natl. Acad. Sci. USA 108: 10650-10655.
20. + T-cell response in patients with chronic hepatitis B. Eur. J. Immunol. 42: 1180-1191.
21. McMahan, R. H., L. Golden-Mason, M. I. Nishimura, B. J. McMahon, M. Kemper, T. M. Allen, D. R. Gretch, and H. R. Rosen. 2010. Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J. Clin. Invest. 120: 4546-4557.
22. Jin, H. T., A. C. Anderson, W. G. Tan, E. E. West, S. J. Ha, K. Araki, G. J. Freeman, V. K. Kuchroo, and R. Ahmed. 2010. Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc. Natl. Acad. Sci. USA 107: 14733-14738.
23. Golden-Mason, L., B. E. Palmer, N. Kassam, L. Townshend-Bulson, S. Livingston, B. J. McMahon, N. Castelblanco, V. Kuchroo, D. R. Gretch, and H. R. Rosen. 2009. Negative immune regulator Tim-3 is overexpressed on T cells in hepatitis C virus infection and its blockade rescues dysfunctional CD4+ and CD8+ T cells. J. Virol. 83: 9122-9130.
24. van de Weyer, P. S., M. Muehlfeit, C. Klose, J. V. Bonventre, G. Walz, and E. W. Kuehn. 2006. A highly conserved tyrosine of Tim-3 is phosphorylated upon stimulation by its ligand galectin-9. Biochem. Biophys. Res. Commun. 351: 571-576. (Pubitemid 44666725)
25. Vega-Carrascal, I., E. P. Reeves, T. Niki, T. Arikawa, P. McNally, S. J. O'Neill, M. Hirashima, and N. G. McElvaney. 2011. Dysregulation of TIM-3-galectin-9 pathway in the cystic fibrosis airways. J. Immunol. 186: 2897-2909.
26. Lee, J., E. W. Su, C. Zhu, S. Hainline, J. Phuah, J. A. Moroco, T. E. Smithgall, V. K. Kuchroo, and L. P. Kane. 2011. Phosphotyrosine-dependent coupling of Tim-3 to T-cell receptor signaling pathways. Mol. Cell. Biol. 31: 3963-3974.
27. Rangachari, M., C. Zhu, K. Sakuishi, S. Xiao, J. Karman, A. Chen, M. Angin, A. Wakeham, E. A. Greenfield, R. A. Sobel, et al. 2012. Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion. Nat. Med. 18: 1394-1400.
28. Lee, M. J., M. Y. Woo, Y. J. Chwae, M. H. Kwon, K. Kim, and S. Park. 2012. Down-regulation of interleukin-2 production by CD4(+) T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription. Immunobiology 217: 986-995.
29. Mujib, S., R. B. Jones, C. Lo, N. Aidarus, K. Clayton, A. Sakhdari, E. Benko, C. Kovacs, and M. A. Ostrowski. 2012. Antigen-independent induction of Tim-3 expression on human T cells by the common γ-chain cytokines IL-2, IL-7, IL-15, and IL-21 is associated with proliferation and is dependent on the phosphoinositide 3-kinase pathway. J. Immunol. 188: 3745-3756.
30. Ramsay, A. G., A. J. Johnson, A. M. Lee, G. Gorgün, R. Le Dieu, W. Blum, J. C. Byrd, and J. G. Gribben. 2008. Chronic lymphocytic leukemia T cells show impaired immunological synapse formation that can be reversed with an immunomodulating drug. J. Clin. Invest. 118: 2427-2437. (Pubitemid 351949771)
31. Kabouridis, P. S. 2006. Lipid rafts in T cell receptor signalling. Mol. Membr. Biol. 23: 49-57.
32. Otáhal, P., P. Angelisová, M. Hrdinka, T. Brdicka, P. Novák, K. Drbal, and V. Horejsí. 2010. A new type of membrane raft-like microdomains and their possible involvement in TCR signaling. J. Immunol. 184: 3689-3696.
33. Filipp, D., O. Ballek, and J. Manning. 2012. Lck, Membrane Microdomains, and TCR Triggering Machinery: Defining the New Rules of Engagement. Front. Immunol. 3: 155.
34. Dupré, L., A. Aiuti, S. Trifari, S. Martino, P. Saracco, C. Bordignon, and M. G. Roncarolo. 2002. Wiskott-Aldrich syndrome protein regulates lipid raft dynamics during immunological synapse formation. Immunity 17: 157-166. (Pubitemid 35245958)
35. Saito, T., and T. Yokosuka. 2006. Immunological synapse and microclusters: the site for recognition and activation of T cells. Curr. Opin. Immunol. 18: 305-313.
36. Chen, L., and D. B. Flies. 2013. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13: 227-242.
37. Cao, E., X. Zang, U. A. Ramagopal, A. Mukhopadhaya, A. Fedorov, E. Fedorov, W. D. Zencheck, J. W. Lary, J. L. Cole, H. Deng, et al. 2007. T cell immunoglobulin mucin-3 crystal structure reveals a galectin-9-independent ligandbinding surface. Immunity 26: 311-321. (Pubitemid 46413908)
38. Yokosuka, T., M. Takamatsu, W. Kobayashi-Imanishi, A. Hashimoto-Tane, M. Azuma, and T. Saito. 2012. Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2. J. Exp. Med. 209: 1201-1217.
39. Li, D., J. J. Molldrem, and Q. Ma. 2009. LFA-1 regulates CD8+ T cell activation via T cell receptor-mediated and LFA-1-mediated Erk1/2 signal pathways. J. Biol. Chem. 284: 21001-21010.
40. Gascoigne, N. R., J. Casas, J. Brzostek, and V. Rybakin. 2011. Initiation of TCR phosphorylation and signal transduction. Front. Immunol. 2: 72.
41. Ou-Yang, C. W., M. Zhu, D. M. Fuller, S. A. Sullivan, M. I. Chuck, S. Ogden, Q. J. Li, and W. Zhang. 2012. Role of LAT in the granule-mediated cytotoxicity of CD8 T cells. Mol. Cell. Biol. 32: 2674-2684.
42. McNeill, L., R. J. Salmond, J. C. Cooper, C. K. Carret, R. L. Cassady-Cain, M. Roche-Molina, P. Tandon, N. Holmes, and D. R. Alexander. 2007. The differential regulation of Lck kinase phosphorylation sites by CD45 is critical for T cell receptor signaling responses. Immunity 27: 425-437. (Pubitemid 47418669)
43. Leitner, J., A. Rieger, W. F. Pickl, G. Zlabinger, K. Grabmeier-Pfistershammer, and P. Steinberger. 2013. TIM-3 does not act as a receptor for galectin-9. PLoS Pathog. 9: e1003253.
44. Lin, J., and A. Weiss. 2003. The tyrosine phosphatase CD148 is excluded from the immunologic synapse and down-regulates prolonged T cell signaling. J. Cell Biol. 162: 673-682. (Pubitemid 37022944)
45. Gingras, A. C., M. Gstaiger, B. Raught, and R. Aebersold. 2007. Analysis of protein complexes using mass spectrometry. Nat. Rev. Mol. Cell Biol. 8: 645-654. (Pubitemid 47106612)
46. Zikherman, J., C. Jenne, S. Watson, K. Doan, W. Raschke, C. C. Goodnow, and A. Weiss. 2010. CD45-Csk phosphatase-kinase titration uncouples basal and inducible T cell receptor signaling during thymic development. Immunity 32: 342-354.
47. Hermiston, M. L., J. Zikherman, and J. W. Zhu. 2009. CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells. Immunol. Rev. 228: 288-311.
48. Nirschl, C. J., and C. G. Drake. 2013. Molecular pathways: coexpression of immune checkpoint molecules: signaling pathways and implications for cancer immunotherapy. Clin. Cancer Res. 19: 4917-4924.